News/ News/ R&D Amgen buys inflammatory diseases drug firm Rodeo for up to $721m Richard Staines Amgen, inflammatory diseases, M&A, R&D, Rodeo Therapeutics 0 Comment Amgen has announced its second acquisition in the space of a month, snapping up Rodeo Therapeutics and its Share X Amgen buys inflammatory diseases drug firm Rodeo for up to $721m https://pharmaphorum.com/news/acquisitive-amgen-buys-inflammatory-diseases-drug-firm-rodeo-for-up-to-721m/